Atlas Trials

Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches

Clinical trial NCT02270957 · COMPLETED

Trial details

NCT number
NCT02270957
Sponsor
Oklahoma Medical Research Foundation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Systemic Lupus Erythematosus
Start date
2014-01-01
Primary completion
2018-12-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.